Biotechnology
Cabinet clears Rs1,500-cr biopharma mission
19 May 2017
Green body protests GEAC nod for GM mustard
13 May 2017
GM mustard gets regulatory approval, awaits SC nod
12 May 2017
With the government’s Genetic Engineering Appraisal Committee approving genetically modified mustard, the condiment is set for commercial cultivation, if the Supreme Court clears an appeal against its introduction
23andMe gets FDA nod to sell genetic tests directly to consumers
07 Apr 2017
For the first time the FDA has allowed a company to sell genetic tests for disease risk directly to consumers, which would tell people if they were at risk of developing conditions like Parkinson’s and Alzheimer’s
Carlyle to sell herbal supplement maker Nature's Bounty
06 Jan 2017
Nature’s Bounty (earlier known as NBTY Inc) that Carlyle acquired in 2010 for $3.8 billion, is currently valued at about $6 billion
Visualizing gene expression with MRI
26 Dec 2016
Monsanto shareholders approve $66-bn acquisition by Bayer
14 Dec 2016
A deal would create a company commanding more than a quarter of the combined world market for seeds and pesticides
SC blocks commercial release of GM mustard
08 Oct 2016
.webp)
.webp)
